Diagnostic performance of the (1→3)-β-d-glucan assay for invasive fungal disease

Clinical Infectious Diseases

Volumn 49, Issue 11, 2009, Pages 1650-1659

  Koo, Sophia ^a,b,c   Bryar, Julie M ^a,d   Page, John H ^d   Baden, Lindsey R ^a,b,c   Marty, Francisco M ^e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CASPOFUNGIN; COTRIMOXAZOLE; FLUCONAZOLE; GLUCAN; IMMUNOGLOBULIN; ITRACONAZOLE; VORICONAZOLE;

ARTICLE; ASPERGILLOSIS; ASPERGILLUS; CANDIDA; CANDIDIASIS; CLINICAL PRACTICE; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; FEBRILE NEUTROPENIA; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMODIALYSIS; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; LIVER DISEASE; LUNG INFILTRATE; LUNG NODULE; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; MYCOSIS; NONHUMAN; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPSIS; SPLEEN DISEASE; STEM CELL TRANSPLANTATION;

ADULT; AGED; AGED, 80 AND OVER; BETA-GLUCANS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOSES; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 72849130457     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/647942     Document Type: Article

References (41)

1. Neofytos D, Horn D, Anaissie E, et al. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 2009; 48:265-273
2. Pagano L, Caira M, Candoni A, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006; 91:1068-1075 (Pubitemid 44208634)
3. Pagano L, Caira M, Nosari A, et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study-Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis 2007; 45:1161-1170 (Pubitemid 47580314) (Pubitemid 47580314)
4. Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev 2005; 18:44-69.
5. Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis 2007; 44: 531-540 (Pubitemid 46233255) (Pubitemid 46233255)
6. Obayashi T, Yoshida M, Mori T, et al. Plasma (1→3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995; 345:17-20.
7. Odabasi Z, Mattiuzzi G, Estey E, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004; 39:199-205. (Pubitemid 38971490) (Pubitemid 38971490)
8. Pazos C, Ponton J, Del Palacio A. Contribution of (1→3)-beta-D- glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol 2005; 43: 299-305. (Pubitemid 40096315) (Pubitemid 40096315)
9. Ellis M, Al-Ramadi B, Finkelman M, et al. Assessment of the clinical utility of serial beta-D-glucan concentrations in patients with persistent neutropenic fever. J Med Microbiol 2008; 57:287-295 (Pubitemid 351358531) (Pubitemid 351358531)
10. Senn L, Robinson JO, Schmidt S, et al. 1,3-β-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis 2008; 46:878-885
11. Mennink-Kersten MA, Verweij PE. Non-culture-based diagnostics for opportunistic fungi. Infect Dis Clin North Am 2006; 20:711-27, viii.
12. Marty FM, Koo S. Role of (1→3)-beta-D-glucan in the diagnosis of invasive aspergillosis. Med Mycol 2009; 47(Suppl 1):S233-40.
13. Kawazu M, Kanda Y, Nannya Y, et al. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1→3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J Clin Microbiol 2004; 42:2733-2741 (Pubitemid 38747529) (Pubitemid 38747529)
14. Kami M, Tanaka Y, Kanda Y, et al. Computed tomographic scan of the chest, latex agglutination test and plasma (1AE3)-beta-D-glucan assay in early diagnosis of invasive pulmonary aspergillosis: a prospective study of 215 patients. Haematologica 2000; 85:745-752 (Pubitemid 30617109)
15. Hachem RY, Kontoyiannis DP, Chemaly RF, Jiang Y, Reitzel R, Raad I. Utility of galactomannan enzyme immunoassay and (1,3) beta-Dglucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. J Clin Microbiol 2009; 47:129-133
16. Persat F, Ranque S, Derouin F, Michel-Nguyen A, Picot S, Sulahian A. Contribution of the (1→3)-{beta}-D-glucan assay for the diagnosis of invasive fungal infections. J Clin Microbiol 2008; 46:1009-1013
17. Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005; 41:654-659 (Pubitemid 41170353) (Pubitemid 41170353)
18. Obayashi T, Negishi K, Suzuki T, Funata N. Reappraisal of the serum (1→3)-b-D-glucan assay for the diagnosis of invasive fungal infections- a study based on autopsy cases from 6 years. Clin Infect Dis 2008; 46:1864-1870.
19. Kanda H, Kubo K, Hamasaki K, et al. Influence of various hemodialysis membranes on the plasma (1→3)-beta-D-glucan level. Kidney Int 2001; 60:319-323 (Pubitemid 32587570) (Pubitemid 32587570)
20. Kato A, Takita T, Furuhashi M, Takahashi T, Maruyama Y, Hishida A. Elevation of blood (1→3)-beta-D-glucan concentrations in hemodialysis patients. Nephron 2001; 89:15-19 (Pubitemid 32799827) (Pubitemid 32799827)
21. Yoshioka T, Ikegami K, Ikemura K, et al. A study on limulus amebocyte lysate (LAL) reactive material derived from dialyzers. Jpn J Surg 1989; 19:38-41. (Pubitemid 19091493) (Pubitemid 19091493)
22. Usami M, Ohata A, Horiuchi T, Nagasawa K, Wakabayashi T, Tanaka S. Positive (1→3)-beta-D-glucan in blood components and release of (1→3)-beta-D-glucan from depth-type membrane filters for blood processing. Transfusion 2002; 42:1189-1195
23. Ikemura K, Ikegami K, Shimazu T, Yoshioka T, Sugimoto T. Falsepositive result in Limulus test caused by Limulus amebocyte lysatereactive material in immunoglobulin products. J Clin Microbiol 1989; 27:1965-1968 (Pubitemid 19208975)
24. Ohata A, Usami M, Horiuchi T, Nagasawa K, Kinoshita K. Release of (1→3)-beta-D-glucan from depth-type membrane filters and their in vitro effects on proinflammatory cytokine production. Artif Organs 2003; 27:728-735 (Pubitemid 37041384) (Pubitemid 37041384)
25. Ogawa M, Hori H, Niiguchi S, Azuma E, Komada Y. False-positive plasma (1→3)-beta-D-glucan test following immunoglobulin product replacement in an adult bone marrow recipient. Int J Hematol 2004; 80:97-98 (Pubitemid 38937885) (Pubitemid 38937885)
26. Marty FM, Lowry CM, Lempitski SJ, Kubiak DW, Finkelman MA, Baden LR. Reactivity of (1→3)-beta-D-glucan assay with commonly used intravenous antimicrobials. Antimicrob Agents Chemother 2006; 50:3450-3453
27. Mennink-Kersten MA, Warris A, Verweij PE. 1,3-beta-D-glucan in patients receiving intravenous amoxicillin-clavulanic acid. N Engl J Med 2006; 354:2834-2835 (Pubitemid 43974215)
28. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-1821.
29. Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001; 97: 1604-1610 (Pubitemid 32217224) (Pubitemid 32217224)
30. Pepe MS. The statistical evaluation of medical tests for classification and prediction. Oxford: Oxford University Press, 2003.
31. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143:29-36.
32. Youden WJ. Index for rating diagnostic tests. Cancer 1950; 3:32-35
33. Nakao A, Yasui M, Kawagoe T, Tamura H, Tanaka S, Takagi H. Falsepositive endotoxemia derives from gauze glucan after hepatectomy for hepatocellular carcinoma with cirrhosis. Hepatogastroenterology 1997; 44:1413-1418 (Pubitemid 27450188)
34. Kimura Y, Nakao A, Tamura H, Tanaka S, Takagi H. Clinical and experimental studies of the limulus test after digestive surgery. Surg Today 1995; 25:790-794
35. Mennink-Kersten MA, Ruegebrink D, Verweij PE. Pseudomonas aeruginosa as a cause of 1,3-β-D-glucan assay reactivity. Clin Infect Dis 2008; 46:1930-1931
36. Marr KA, Laverdiere M, Gugel A, Leisenring W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis 2005; 40:1762-1769 (Pubitemid 40799945) (Pubitemid 40799945)
37. Marty FM, Koo S, Bryar J, Baden LR. (1→3)beta-D-glucan assay positivity in patients with Pneumocystis (carinii) jiroveci pneumonia. Ann Intern Med 2007; 147:70-72 (Pubitemid 351664641)
38. Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006; 42: 1417-1427
39. Tasaka S, Hasegawa N, Kobayashi S, et al. Serum indicators for the diagnosis of pneumocystis pneumonia. Chest 2007; 131:1173-1180 (Pubitemid 46608722) (Pubitemid 46608722)
40. Okamoto K, Yamamoto T, Nonaka D, et al. Plasma (1→3)-beta-Dglucan measurement and polymerase chain reaction on sputum as practical parameters in Pneumocystis carinii pneumonia. Intern Med 1998; 37:618-621 (Pubitemid 128519102)
41. Glasziou P, Irwig L, Deeks JJ. When should a new test become the current reference standard? Ann Intern Med 2008; 149:816-822